Publication Name	World Journal of Virology
Manuscript ID	66296
Country	Spain

Received	2021-03-24 22:21
Peer-Review Started	2021-03-24 22:26
To Make the First Decision
Return for Revision	2021-05-05 21:17
Revised	2021-05-18 14:40
Second Decision	2021-08-13 02:57
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-08-13 07:27
Articles in Press	2021-08-13 07:27
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-10-06 09:12
Typeset the Manuscript	2021-11-18 05:28
Publish the Manuscript Online	2021-11-22 09:40

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Impact of COVID-19 on liver disease: From the experimental to the clinic perspective
Manuscript Source	Invited Manuscript
All Author List	Sheila Gato, Ana Lucena-Valera, Rocío Muñoz-Hernández, José Manuel Sousa, Manuel Romero-Gómez and Javier Ampuero
Funding Agency and Grant Number
Corresponding Author	Javier Ampuero, MD, MSc, PhD, Doctor, Doctor, Professor, Senior Scientist, Digestive Department, Hospital Universitario Virgen del Rocio, Avda. Manuel Siurot s/n, Sevilla 41013, Spain. javi.ampuero@gmail.com
Key Words	SARS-CoV-2; COVID 19; Liver disease; Transaminases
Core Tip	The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a critical threat to the global public health. Beyond the respiratory symptoms, some patients with COVID-19 show liver damage. In this scenario, it has been suggested that there might be a specific relationship between SARS-CoV-2 infection and liver injury.
Publish Date	2021-11-22 09:40
Citation	Gato S, Lucena-Valera A, Muñoz-Hernandez R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311
URL	https://www.wjgnet.com/2220-3249/full/v10/i6/301.htm
DOI	https://dx.doi.org/10.5501/wjv.v10.i6.301

Full Article (PDF)	WJV-10-301.pdf
Full Article (Word)	WJV-10-301.docx
Manuscript File	66296_Auto_Edited-JPY-Webster J-Clear.docx
Answering Reviewers	66296-Answering reviewers.pdf
Audio Core Tip	66296-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	66296-Conflict-of-interest statement.pdf
Copyright License Agreement	66296-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	66296-Language certificate.pdf
Peer-review Report	66296-Peer-review(s).pdf
Scientific Misconduct Check	66296-Scientific misconduct check.pdf
Scientific Editor Work List	66296-Scientific editor work list.pdf
CrossCheck Report	66296-CrossCheck report.pdf